Cubist Systematic Strategies, LLC Adaptive Biotechnologies Corp Transaction History

Cubist Systematic Strategies, LLC

  • $20.3 Billion
  • Q2 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 458,871 shares of ADPT stock, worth $8.18 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
458,871
Holding current value
$8.18 Million
% of portfolio
0.03%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$6.83 - $12.16 $3.13 Million - $5.58 Million
458,871 New
458,871 $5.35 Million
Q4 2024

Feb 14, 2025
BUY
$4.37 - $6.78 $69,120 - $107,239
15,817 Added 5.28%
315,098 $1.89 Million
Q3 2024

Nov 14, 2024
BUY
$3.37 - $5.12 $1.01 Million - $1.53 Million
299,281 New
299,281 $1.53 Million
Q1 2024

May 15, 2024
SELL
$2.88 - $4.8 $109,385 - $182,308
-37,981 Reduced 42.92%
50,502 $162,000
Q4 2023

Feb 14, 2024
BUY
$3.46 - $5.33 $306,151 - $471,614
88,483 New
88,483 $433,000
Q1 2023

May 15, 2023
SELL
$7.8 - $10.11 $3.1 Million - $4.02 Million
-397,982 Reduced 67.15%
194,705 $1.72 Million
Q4 2022

Feb 14, 2023
BUY
$6.26 - $9.34 $690,966 - $1.03 Million
110,378 Added 22.89%
592,687 $4.53 Million
Q3 2022

Nov 14, 2022
BUY
$6.5 - $12.67 $1.07 Million - $2.09 Million
164,982 Added 51.99%
482,309 $3.43 Million
Q2 2022

Aug 15, 2022
BUY
$6.4 - $14.73 $47,852 - $110,136
7,477 Added 2.41%
317,327 $2.57 Million
Q1 2022

May 16, 2022
BUY
$10.12 - $28.9 $2.24 Million - $6.39 Million
221,235 Added 249.66%
309,850 $4.3 Million
Q4 2021

Feb 14, 2022
BUY
$25.17 - $36.85 $1.16 Million - $1.7 Million
46,082 Added 108.34%
88,615 $2.49 Million
Q3 2021

Nov 15, 2021
BUY
$30.02 - $39.87 $535,046 - $710,603
17,823 Added 72.13%
42,533 $1.45 Million
Q2 2021

Aug 16, 2021
SELL
$32.22 - $44.59 $1.9 Million - $2.63 Million
-59,054 Reduced 70.5%
24,710 $1.01 Million
Q1 2021

May 17, 2021
BUY
$37.26 - $67.74 $2.9 Million - $5.27 Million
77,844 Added 1314.93%
83,764 $3.37 Million
Q4 2020

Feb 16, 2021
BUY
$45.01 - $65.47 $118,691 - $172,644
2,637 Added 80.32%
5,920 $350,000
Q3 2020

Nov 16, 2020
BUY
$35.79 - $48.81 $2,970 - $4,051
83 Added 2.59%
3,283 $160,000
Q2 2020

Aug 14, 2020
SELL
$24.95 - $48.38 $508,031 - $985,113
-20,362 Reduced 86.42%
3,200 $155,000
Q1 2020

May 15, 2020
BUY
$16.96 - $34.16 $399,611 - $804,877
23,562 New
23,562 $655,000

Others Institutions Holding ADPT

# of Institutions
267
Shares Held
149M
Call Options Held
168K
Put Options Held
25.2K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $2.55B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email